Cargando…

Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment

BACKGROUND: The Australian National Bowel Cancer Screening Program (NBCSP) provides biennial immunochemical faecal occult blood test (iFOBT) screening for people aged 50–74 years. Previous work has quantified the number of colorectal cancer (CRC) deaths prevented by the NBCSP and has shown that it i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Worthington, Joachim, Lew, Jie-Bin, Feletto, Eleonora, Holden, Carol A., Worthley, Daniel L., Miller, Caroline, Canfell, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996821/ https://www.ncbi.nlm.nih.gov/pubmed/32012174 http://dx.doi.org/10.1371/journal.pone.0227899

Ejemplares similares

Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia
por: Goldsbury, David E., et al.
Publicado: (2021)

Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort
por: Yap, Sarsha, et al.
Publicado: (2023)

Engaging lower screening groups: a field experiment to evaluate the impact of a multiwave national campaign on participation in the National Bowel Cancer Screening Program
por: Gascoyne, Claudia, et al.
Publicado: (2023)

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
por: Nickson, Carolyn, et al.
Publicado: (2023)

Socioeconomic disparities in colorectal cancer survival: contributions of prognostic factors in a large Australian cohort
por: Yu, Xue Qin, et al.
Publicado: (2021)

783 IMPACT OF COVID-19 RELATED DISRUPTIONS TO COLORECTAL CANCER SCREENING PROGRAMS IN THREE COUNTRIES: A COMPARATIVE MODELLING STUDY
por: De Jonge, Lucie, et al.
Publicado: (2021)

Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040
por: Luo, Qingwei, et al.
Publicado: (2022)

Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study
por: Velentzis, Louiza S., et al.
Publicado: (2021)

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
por: van Wifferen, Francine, et al.
Publicado: (2022)

Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
por: Worthington, Joachim, et al.
Publicado: (2023)

Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice
por: Holden, Carol A, et al.
Publicado: (2020)

Quantifying disparities in cancer incidence and mortality of Australian residents of New South Wales (NSW) by place of birth: an ecological study
por: Feletto, Eleonora, et al.
Publicado: (2015)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
por: de Jonge, Lucie, et al.
Publicado: (2021)

Changes in cancer incidence and mortality in Australia over the period 1996–2015
por: Luo, Qingwei, et al.
Publicado: (2020)

SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program
por: McIntosh, Jennifer G., et al.
Publicado: (2023)

Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over
por: Sarich, Peter, et al.
Publicado: (2020)

Australia's National Bowel Cancer Screening Program: does it work for Indigenous Australians?
por: Christou, Aliki, et al.
Publicado: (2010)

Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease
por: Shupo, Francis, et al.
Publicado: (2023)

Home medicines reviews: a national survey of Australian accredited pharmacists’ health service time investment
por: Patounas, Marea, et al.
Publicado: (2021)

An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017
por: Feletto, Eleonora, et al.
Publicado: (2022)

Developing the environmental and lifestyle exposure assessment (ELEA) tool for cancer epidemiology research in low resource settings
por: Feletto, Eleonora, et al.
Publicado: (2016)

Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival
por: Roder, David, et al.
Publicado: (2019)

Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia
por: Feletto, Eleonora, et al.
Publicado: (2020)

The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program
por: Wood, Anna, et al.
Publicado: (2022)

Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study
por: Velentzis, Louiza S., et al.
Publicado: (2016)

Integrating nutrition and obesity prevention considerations into institutional investment decisions regarding food companies: Australian investment sector perspectives
por: Robinson, Ella, et al.
Publicado: (2022)

The National Children’s Study: A Critical National Investment
por: Trasande, Leonardo, et al.
Publicado: (2004)

The developmental high wire: Balancing resource investment in immunity and reproduction
por: Breiner, Daniel J., et al.
Publicado: (2022)

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
por: Legood, Rosa, et al.
Publicado: (2012)

Workforce participation in relation to cancer diagnosis, type and stage: Australian population-based study of 163,556 middle-aged people
por: Thandrayen, Joanne, et al.
Publicado: (2021)

Personal investing
por: Biafore, Bonnie, et al.
Publicado: (2010)

Investing in breastfeeding – the world breastfeeding costing initiative
por: Holla-Bhar, Radha, et al.
Publicado: (2015)

Reproductive Investment and Health Costs in Roma Women
por: Čvorović, Jelena, et al.
Publicado: (2017)

Costs dictate strategic investment in dominance interactions
por: Dehnen, Tobit, et al.
Publicado: (2022)

Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations
por: Velentzis, Louiza S., et al.
Publicado: (2017)

Poor self-rated oral health associated with poorer general health among Indigenous Australians
por: Ju, Xiangqun, et al.
Publicado: (2021)

Australian National University Group Theory Program
por: Kovács, L
Publicado: (1990)

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
por: Smith, Megan A., et al.
Publicado: (2016)

Developing Human Capital: Using Analytics to Plan and Optimize Your Learning and Development Investments
por: Walker, Lew
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3he60l3n0t6qe39uqqf4otiqpp